abstract The putative voltage-sensitive release mechanism (VSRM) was investigated in rabbit cardiac myocytes at 37 Њ C with high resistance microelectrodes to minimize intracellular dialysis. When the holding potential was adjusted from Ϫ 40 to Ϫ 60 mV, the putative VSRM was expected to operate alongside CICR. Under these conditions however, we did not observe a plateau at positive potentials of the cell shortening versus voltage relationship. The threshold for cell shortening changed by Ϫ 10 mV, but this resulted from a similar change of the threshold for activation of inward current. Cell shortening under conditions where the putative VSRM was expected to operate was blocked in a dose dependent way by nifedipine and CdCl 2 and blocked completely by NiCl 2 . "Tail contractions" persisted in the presence of nifedipine and CdCl 2 but were blocked completely by NiCl 2 . Block of early outward current by 4-aminopyridine and 4-acetoamido-4 Ј -isothiocyanato-stilbene-2,2 Ј -disulfonic acid (SITS) demonstrated persisting inward current during test depolarizations despite the presence of nifedipine and CdCl 2 . Inward current did not persist in the presence of NiCl 2 . A tonic component of cell shortening that was prominent during depolarizations to positive potentials under conditions selective for the putative VSRM was sensitive to rapidly applied changes in superfusate [Na ϩ ] and to the outward Na ϩ /Ca 2 ϩ exchange current blocking drug KB-R7943. This component of cell shortening was thought to be the result of Na ϩ /Ca 2 ϩ exchange-mediated excitation contraction coupling. Cell shortening recorded under conditions selective for the putative VSRM was increased by the enhanced state of phosphorylation induced by isoprenaline (1 M) and by enhancing sarcoplasmic reticulum Ca 2 ϩ content by manipulation of the conditioning steps. Under these conditions, cell shortening at positive test depolarizations was converted from tonic to phasic. We conclude that the putative VSRM is explained by CICR with the Ca 2 ϩ "trigger" supplied by unblocked L-type Ca 2 ϩ channels and Na ϩ /Ca 2 ϩ exchange.
I N T R O D U C T I O N
The voltage-sensitive release mechanism (VSRM)* is a recently described and controversial (Piacentino et al., 2000; Trafford and Eisner, 1998; Wier and Balke, 1999) mechanism proposed for excitation-contraction (EC) coupling in cardiac muscle (Ferrier and Howlett, 1995; Hobai et al., 1997b) . Under certain experimental conditions, the putative VSRM is described as capable of mediating SR Ca 2 ϩ release and cell shortening in isolated myocytes in response to membrane depolarization per se. These conditions include a physiological experimental temperature of 37 Њ C, a fully loaded SR and a holding potential negative to Ϫ 40 mV as the putative VSRM is said to undergo complete steady-state inactivation at this potential Howlett et al., 1998) . If intracellular dialysis with patch pipettes occurs, the putative VSRM is supported only when the phosphorylation state of the cell is enhanced by inclusion of cAMP in the pipette filling solution (Hobai et al., 1997b; Ferrier et al., 1998) . When these conditions are fulfilled, properties of the EC coupling observed include a voltage threshold for activation negative to that for L-type Ca 2 ϩ current (I Ca(L) ), persisting cell shortening or SR Ca 2 ϩ release at positive potentials in the region of E Ca resulting in sigmoid shaped voltage dependence, and persisting cell shortening or SR Ca 2 ϩ release during exposure to L-type Ca 2 ϩ channel blocking agents. These have been proposed as defining features of the putative VSRM that has now been described in guinea-pig (Ferrier and Howlett, 1995; Ferrier et al., 1998 Ferrier et al., , 2000 Howlett et al., 1998; Mason and Ferrier, 1999) , rabbit (Hobai et al., 1997b) , rat (Hobai et al., 1997b; Howlett et al., 1998) , hamster (Howlett et al., 1999) , human atrial myocytes (Van Wagoner et al., 1999) , and also in heart failure models in hamster (Howlett et al., 1999) and rat (Sjaastad et al., 2000) . 354 The VSRM in Rabbit Is Explained by CICR
The experimental conditions necessary for demonstration of the putative VSRM have significant effects on the properties of cardiac myocyte calcium handling. This raises the possibility that modification of CICR by these conditions may produce EC coupling with features of the putative VSRM. There are a number of examples of this effect.
Small amplitude depolarizations in rat myocytes to negative test potentials from a holding potential of Ϫ 50 mV have been shown to elicit I Ca(L) , Ca 2 ϩ transients, and cell shortening (Talo et al., 1990) . In another study, Ca 2 ϩ sparks were recorded in rat myocytes during voltage ramps over a negative voltage range between Ϫ 80 and Ϫ 40 mV (Cannell et al., 1995) . The spatial and temporal distribution as well as the stochastic nature of the sparks led to the conclusion that they were under the control of single L-type Ca 2 ϩ channel openings. These studies illustrate the possibility that negative holding potentials permit contractions mediated by CICR at negative test potentials.
Phosphorylation of the L-type Ca 2 ϩ channel, e.g., by intracellular cAMP results in an increased open probability of the channel and whole cell I Ca(L) (McDonald et al., 1994) . The voltage threshold for activation of I Ca (L) has been shown in rat and canine myocytes to shift to more negative potentials when intracellular [cAMP] was increased after application of isoprenaline (1-3 M) . In these experiments, fractional potentiation of I Ca(L) was greatest during depolarizations to negative potentials at the foot of its activation curve (Tiaho et al., 1991) and was shown to be capable of eliciting SR Ca 2 ϩ release (Sipido et al., 2000) . These results also indicate the possibility that increased intracellular [cAMP] will allow contractions mediated by CICR at negative test potentials.
In guinea-pig ventricular myocytes at 37 Њ C, the voltage threshold for cell shortening shifted from Ϫ 35 to Ϫ 40 mV and the cell shortening versus voltage curve became sigmoidal when measures were taken to preserve SR Ca 2 ϩ stores (Isenberg and Wendt Gallitelli, 1989) . In these experiments, the holding potential of Ϫ 45 mV would have inactivated the putative VSRM and SR Ca 2 ϩ overload may have permitted CICR to mimic its described features.
The response to L-type Ca 2 ϩ channel blockers is also influenced by the conditions necessary for demonstration of the putative VSRM. Block by dihydropyridines or multivalent heavy metal cations is voltage dependent. Block is therefore less complete when depolarizations are applied from more negative holding potentials or when depolarizations are applied to negative activating potentials (Kokubun et al., 1986; Lansman et al., 1986) . I Ca(L) amplitude is steeply temperature dependent and experimental temperature also affects the response to L-type Ca 2 ϩ channel blockers. In one study, the Q 10 for the maximum amplitude of I Ca(L) increased from 2.4 to 4.2 during inhibition by nifedipine (Allen and Chapman, 1992) . Phosphorylation of the L-type Ca 2 ϩ channel also results in reduced sensitivity to channel blockers (Hobai et al., 2000) . These phenomena illustrate the potential for I Ca(L) to persist under conditions believed to be selective for the putative VSRM when I Ca(L) is presumed to be blocked completely.
A further effect of negative holding potential is that on steady-state inactivation of the transient outward current (I to ). I to starts to inactivate at Ϫ 70 mV and the half maximal inactivation point lies at Ϫ 40 mV. The current is manifest as a depolarization-activated immediate outward current with an activation voltage threshold of Ϫ 20 mV and maximum amplitude increasing with depolarization to more positive potentials (Giles and Imaizumi, 1988; Hiraoka and Kawano, 1989) . It follows, therefore, that I to amplitude will always be greater under conditions necessary for demonstration of the putative VSRM. The presence of I to as the dominant early membrane current during conditions supporting the putative VSRM may mask coexisting I Ca(L) .
The effects of SR Ca 2 ϩ "overload" have been well studied. In Ca 2 ϩ overloaded cells, the probability of spontaneous Ca 2 ϩ sparks is increased (Cheng et al., 1993) , spontaneous propagating waves of contraction , or intracellular Ca 2 ϩ (Orchard et al., 1983; Wier et al., 1987; Trafford et al., 1993) may be observed and fractional SR Ca 2 ϩ release activated by CICR is increased (Han et al., 1994; Janczewski et al., 1995; Shannon et al., 2000) . It has also been pointed out that after SR Ca 2 ϩ loading, a Ca 2 ϩ transient could be released by a Ca 2 ϩ trigger that would usually be too small to initiate release under control levels of SR Ca 2 ϩ content (Fabiato, 1983; Trafford et al., 1993; Han et al., 1994; Bassani et al., 1995; Spencer and Berlin, 1995; Dupont et al., 1996; Shannon et al., 2000) . Phosphorylation of phospholamban, e.g., by intracellular cAMP, increases the rate of SR Ca 2 ϩ pumping and therefore SR Ca 2 ϩ content (Sham et al., 1991; Bers, 2001) . Phosphorylation of the SR Ca 2 ϩ release channel increases its sensitivity to activating Ca 2 ϩ although varying effects may be produced by different phosphorylation systems (Hain et al., 1995; Lokuta et al., 1995; duBell et al., 1996) . Elevated intracellular cAMP has been a mandatory condition for the putative VSRM in a number of reports (Hobai et al., 1997b; Ferrier et al., 1998; Zhu and Ferrier, 2000) . These further effects on CICR of elevated intracellular cAMP may have contributed to EC coupling mimicking the putative VSRM. Na ϩ /Ca 2 ϩ exchange is able to mediate cell shortening in the absence of L-type Ca 2 ϩ channel activation Bers et al., 1988; Beuckelmann and Wier, 1989) . Steps have rarely been taken to block Na ϩ /Ca 2 ϩ exchange during routine demonstration of the putative VSRM. It has been shown in guinea-pig myocytes (Vornanen et al., 1994) and in rat myocytes (Wasserstrom and Vites, 1996) that the effect of increased experimental temperature on Na ϩ /Ca 2 ϩ exchange resulted in conversion of the phasic tension versus voltage curve from bell shaped to sigmoid. In the study of Wasserstrom and Vites (1996) , the amplitude of cell shortening was also increased when the holding potential was adjusted to a more negative value. Under conditions where EC coupling was mediated by Na ϩ /Ca 2 ϩ exchange in rabbit myocytes, the cell shortening versus voltage curve changed from bell shaped to sigmoid with regenerative, oscillatory Ca 2 ϩ release when SR Ca 2 ϩ content was increased by intracellular dialysis with high [Na ϩ ] . These studies demonstrate that Na ϩ /Ca 2 ϩ exchange is capable of reproducing one of the defining features of the putative VSRM. It has also been shown that Na ϩ /Ca 2 ϩ exchange is enhanced by dialysis with intracellular cAMP (Perchenet et al., 2000) .
In many studies, failure of EC coupling has been observed despite experimental conditions compatible with operation of the putative VSRM. Thus, cell shortening in guinea-pig was a bell-shaped function of voltage during depolarization from a holding potential of Ϫ 68 mV (Beuckelmann and Wier, 1988) and was blocked by NiCl 2 (5 mM) in myocytes at their resting membrane potential at 34-37 Њ C (Levesque et al., 1994; Levi et al., 1994) . The Ca 2 ϩ transient elicited in rat by depolarization from a holding potential between Ϫ 70 and Ϫ 80 mV at 34-37 Њ C was blocked by NiCl 2 (5 mM) Ϯ nifedipine (20 M) (Hancox and Levi, 1995; Wasserstrom and Vites, 1996) .
The most notable failure to elicit the putative VSRM occurred when all necessary experimental conditions were present together in field stimulated rabbit myocytes at their resting membrane potential at 36ЊC. In this experiment, the Ca 2ϩ transient and cell shortening were blocked by nifedipine (20 M) and NiCl 2 (5 mM) (Levi and Issberner, 1996) . The putative VSRM does not, therefore, appear to be a robust mechanism of EC coupling.
A large body of evidence suggests therefore that under appropriate conditions, CICR is able to generate EC coupling with properties resembling the hypothesized VSRM. The present series of experiments have been devised to determine the contribution of CICR to the hypothesized VSRM. We have used a physiological superfusing solution in preference to the low [Na ϩ ] solution used by Ferrier and Howlett and intracellular dialysis was minimized with the use of sharp microelectrodes. We find that under the conditions recommended for demonstration of the putative VSRM, either the properties of CICR are modified to the point where VSRM-like behavior is produced or EC coupling is blocked completely. In this respect our results are in broad agreement with those of Piacentino et al. (2000) .
M A T E R I A L S A N D M E T H O D S

Myocyte Isolation
Isolated cardiac myocytes were prepared from adult male New Zealand white rabbits using a modification of methods which have been described in detail elsewhere (MacLeod and Harding, 1991) . Rabbits were anticoagulated and killed by intravenous injection of 2,500 i.u. heparin (Leo Laboratories Ltd.) and 300 mg pentobarbitone (Rhone Merieux), respectively. Left ventricular myocytes were isolated using 0.5 mg ml Ϫ1 collagenase (204 i.u. mg Ϫ1 , Worthington Biochemical Corporation) and 0.5 mg ml Ϫ1 hyaluronidase (330 i.u. mg Ϫ1 , Sigma-Aldrich). After isolation, the cells were stored in Dulbecco's modified Eagle's medium (GIBCO BRL) at room temperature and used within 10 h.
Experimental Setup
A cell superfusion system was designed to maximize switching speed between solutions while minimizing disturbance of experimental temperature. The setup was similar to that described previously (Terracciano et al., 2001) . Briefly, a superfusion chamber with a volume of 20 l was mounted on the stage of an inverted microscope. The floor of the superfusion chamber was formed by a glass microscope coverslip. Cells were allowed to settle for up to 5 min on the glass coverslip forming the base of the chamber. Adhesion was facilitated by prior application of mouse laminin. Superfusing solutions were conducted to the chamber by means of polyethylene tubing enclosed within a 1.5-m long silicon rubber insulating jacket extending to within 15 mm of the chamber inlet. A "zero dead space" 4:1 teflon manifold was incorporated into the wall of the chamber and solution switching was controlled by means of four solenoid valves. Flow rate was maintained at Ϸ3 ml min Ϫ1 which permitted solution switching to be 95% complete within 1 s and was increased to Ϸ8 ml min Ϫ1 before application of caffeine. All experiments were performed at 37ЊC and the temperature profile during a solution switch demonstrated a maximum perturbation of Ϫ0.5ЊC with recovery to baseline within 4 s.
Electrophysiological Recordings
Micropipettes were pulled from 1.5-mm filamented borosilicate glass capillaries (Harvard Apparatus Ltd.) with a mechanical pipette puller (P-87; Sutter Instrument Co.) adjusted to obtain microelectrode resistances of 12-30 M⍀ when filled with a 2-M KCl-based solution. Microelectrodes were connected to an Axoclamp-2A amplifier (Axon Instruments, Inc.). The amplifier was coupled via a Digidata 1200 interface (Axon Instruments, Inc.) to a computer that generated electrophysiological protocols, controlled the solenoid valves, and stored experimental data using pCLAMP 6.0.3 software (Axon Instruments, Inc.). Membrane current was recorded in discontinuous single electrode voltage clamp (dSEVC) mode enabling voltage clamp with a single high resistance microelectrode. Continuous monitoring on a dedicated oscilloscope of the "monitor output" triggered at the switching frequency enabled optimal micropipette capacitance compensation. With optimal capacitance compensation, current flow settled rapidly to baseline without overshoot during the latter part of the duty cycle, ensuring faithful voltage recording. Gain (0.3-0.8 nA mV Ϫ1 ) and sampling rate (7-12 kHz) were advanced to maximum values allowing complete settling of current
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The VSRM in Rabbit Is Explained by CICR without overshoot. These settings allowed maximally square voltage steps to be obtained. With minimization of sources of external noise and optimal setup of the voltage clamp, dSEVC resulted in Յ2 mV overshoot beyond the command potential during activation of I Ca(L) with peak amplitudes up to Ϫ2 nA at 37ЊC as encountered in these experiments (Fig. 1) . dSEVC has previously been used successfully in the investigation of I Ca(L) in isolated mammalian myocytes (e.g., Mitchell et al., 1987; Egan et al., 1989; Levi et al., 1993) . Cell capacitance was determined by integration of the capacitance current recorded during 5 mV hyperpolarizing and depolarizing steps under voltage clamp between Ϫ70 and Ϫ75 mV. Changes in cell length were measured by video edge detection as described previously (Steadman et al., 1988) .
Solutions
The following solutions were made up in ultra-pure water produced by running distilled water through a Milli-Q water purification system (Millipore). Concentrations are given in mM unless indicated otherwise. Chemicals were obtained from B.D.H., Merck Ltd unless indicated otherwise. Normal tyrode: NaCl 140, KCl 6, CaCl 2 2, MgCl 2 1, glucose 10, HEPES 10, pH titrated to 7.4 at 37ЊC with NaOH Ϸ6.
Electrode-filling solution: KCl 2M, HEPES 10, EGTA 100 M, pH titrated to 7.2 with KOH.
Low sodium/calcium solution: NaCl 50, LiCl 90, KCl 6, CaCl 2 0.7, MgCl 2 2, glucose 10, HEPES 10, pH titrated to 7.4 at 37ЊC with LiOH Ϸ6.
Inward Na ϩ /Ca 2ϩ exchange current activating solution: NaCl 140, KCl 6, CaCl 2 0.7, MgCl 2 2, glucose 10, HEPES 10, pH titrated to 7.4 at 37ЊC with NaOH Ϸ6.
Outward Na ϩ /Ca 2ϩ exchange current activating solution: LiCl 140, KCl 6, CaCl 2 4, MgCl 2 1, glucose 10, HEPES 10, pH titrated to 7.4 at 37ЊC with NaOH Ϸ6.
The following stock solutions were made up in Milli-Q water and refrigerated unless indicated otherwise. They were added to experimental solutions as required.
Lignocaine 250 (Sigma-Aldrich), TTX 3 (citrate buffered, lyophilized solid form, solution frozen at Ϫ20ЊC, obtained from Calbiochem and Alomone Labs), CdCl 2 100, NiCl 2 500, nifedipine 30 (Sigma-Aldrich) (in ethanol, stored at Ϫ20ЊC, final solution protected from light), L-isoprenaline 0.1 (Sigma-Aldrich) (in ascorbic acid 0.1, frozen and stored for Ͻ8 h), 4 aminopyridine (4AP) 500 (Sigma-Aldrich), KB-R7943 10 (in dimethyl sulphoxide (DMSO), stored at Ϫ20ЊC, gift from Kanebo Co. Ltd., Osaka 534, Japan). Solvents in appropriate dilutions were added to control solutions. The drugs 4-acetoamido-4Ј-isothiocyanatostilbene-2,2Ј-disulfonic acid (SITS, final solution protected from light) (Sigma-Aldrich) and caffeine were added directly to experimental solutions in powder form.
Analysis
Averaging and integration of membrane currents was achieved using the "Analyze/Operators" function of CLAMPFIT 6.0.3. Data are expressed as mean Ϯ SE. Statistical tests of differences between two groups were performed with the paired, two-tailed Student's t test.
R E S U L T S
The Effect of Holding Potential on Cell Shortening
The first series of experiments was designed to establish the effect on cell shortening of adjusting the holding potential to a value supporting the putative VSRM. The experimental protocol is shown in Fig. 2 A. SR Ca 2ϩ content was maintained and kept constant by the application under voltage clamp of a conditioning train consisting of 10 steps from Ϫ80 to 60 mV for 300 ms repeated at 1 Hz. The membrane was then depolarized to a holding potential of Ϫ45 or Ϫ40 mV to establish CICRselective recording conditions or to a holding potential of Ϫ65 or Ϫ60 mV to establish conditions where the putative VSRM could operate alongside CICR. This holding period was imposed for 4 s and when the potential was Ϫ65 or Ϫ60 mV, lignocaine (500 M) or TTX (30 M) was applied in order to block I Na . In a proportion of cells, lignocaine or TTX was also applied when the holding potential was Ϫ45 or Ϫ40 mV. After the holding period, the membrane was depolarized to test potentials between Ϫ65 and Ϫ30 mV in 5-mV increments and between Ϫ30 and 80 mV in 10-mV increments.
Under CICR-selective conditions, the voltage threshold for cell shortening occurred at Ϫ40 mV (Fig. 2 B) . With depolarization from the holding potential of Ϫ65 or Ϫ60 mV, the threshold for cell shortening became more negative and occurred at Ϫ50 mV. This negative movement of the voltage threshold for cell shortening was, however, accompanied by a negative movement of the threshold for activation of phasic inward current, from Ϫ35 to Ϫ40 mV. This is shown more clearly in Fig. 2 D, which demonstrates selected records from Fig. 2 B drawn to a larger scale. The threshold for cell shortening under either CICR-selective conditions or conditions where the putative VSRM was supported occurred at a potential negative to that for phasic inward current. Cell shortening at these potentials was tonic and maintained. This demonstrated that the appearance of cell shortening at a voltage negative to the voltage threshold for phasic inward current was not a defining property of the putative VSRM. Although cell shortening with small depolarizations was not accompanied by phasic inward current, it is seen clearly in Fig. 2 B that noninactivating inward current occurred.
Under CICR-selective conditions, peak shortening occurred between 0 and 20 mV and its voltage dependence corresponded closely with that of peak inward current (Fig. 2 C) . Inward current amplitude was measured as peak inward current subtracted from steady-state current at the end of the depolarizing step and was presumed to represent I Ca (L) . Cell shortening at positive potentials was not eliminated, despite depolarizations to 80 mV. When the holding potential was adjusted to Ϫ65 or Ϫ60 mV, peak cell shortening continued to occur around 0 mV 
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The VSRM in Rabbit Is Explained by CICR and decreased with more positive test depolarizations. Cell shortening under these conditions therefore continued to reflect the voltage dependence of inward current as it did under CICR-selective conditions. Thus, although conditions permitting operation of the putative VSRM were established, the voltage dependence of cell shortening failed to fulfil the predictions of the VSRM hypothesis and did not reach a plateau at positive potentials (Ferrier and Howlett, 1995; Hobai et al., 1997b) .
The Effect of Holding Potential on L-type Ca 2ϩ Current
An experiment to confirm the dependence of the voltage threshold for I Ca(L) on holding potential is illustrated in Fig. 3 A. Inward currents were elicited from a holding potential of Ϫ40 mV by voltage steps of 100 ms. Depolarizations were applied to test potentials between Ϫ40 and 0 mV in 5-mV increments and repeated at a frequency of 2 Hz. TTX (30 M) was applied 4 s before the first step. Nifedipine (60 M) was then added during steps to 0 mV at 0.5 Hz for 30 s while its use-dependent effect was becoming established and the protocol was repeated. L-type calcium current was measured as the nifedipine-sensitive component by subtraction of corresponding traces. The experimental protocol was repeated with measurement of L-type Ca 2ϩ current elicited by depolarizations from a holding potential of Ϫ60 mV. These experiments were conducted in a separate population of cells as the effects of nifedipine were only partially reversible. Conditioning steps were not used in order to minimize time between obtaining corresponding traces in the presence and absence of nifedipine. When the holding potential was Ϫ60 mV, phasic I Ca(L) was detectable during depolarization to Ϫ50 mV in 4/19 cells, to Ϫ45 mV in 5/19 cells, and to Ϫ40 mV in 9/19 cells. An example of a cell with a voltage threshold for I Ca(L) of Ϫ50 mV is shown in Fig. 3 B. The rapid initial currents seen during the steps to Ϫ50 and Ϫ45 mV represent an unsubtracted component of capacitance current. As the peak amplitude of capacitance current flowing during these experiments was of the order of 3 nA, these residuals of Ϸ100 pA amplitude and Ͻ3 ms duration were felt to represent satisfactory subtraction. The I-V curve obtained from these data demonstrated the voltage threshold for I Ca(L) to be Ϫ50 mV when measured 
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The VSRM in Rabbit Is Explained by CICR from a holding potential of Ϫ60 mV (Fig. 3 C) . This corresponded closely with the voltage threshold for activation of cell shortening shown in Fig. 2 B. Mean data from identical experiments performed from a holding potential of Ϫ40 mV were plotted on the same axes for comparison (Fig. 3 C) . This demonstrated that when holding potential was adjusted from Ϫ40 to Ϫ60 mV, there was a corresponding Ϫ15-mV shift in the voltage threshold for I Ca(L) activation from Ϫ35 to Ϫ50 mV. In other cells, small depolarizations from a holding potential of Ϫ60 mV resulted in activation of maintained I Ca(L) in the absence of a phasic component. An example of this phenomenon is shown in Fig. 3 D, where inward current activated with depolarization to Ϫ50, Ϫ40, and Ϫ30 mV before phasic I Ca(L) appeared with depolarization to Ϫ20 mV. The maintained component of the nifedipine-sensitive current is plotted as a function of voltage (Fig. 3 E) . The voltage threshold for these maintained currents lay also at Ϫ50 mV. Their voltage dependence was compatible with their identity as I Ca(L) window current resulting from incomplete steady-state inactivation of L-type Ca 2ϩ channels within the voltage range shown. Thus, the effect of holding potential on the voltage threshold of cell shortening was shown to operate via an effect of holding potential on the voltage threshold for I Ca(L) . It seems likely that the tonic cell shortening recorded with small depolarizations corresponds with the maintained component of I Ca(L) .
Cell Shortening under Recording Conditions Selective for the Putative VSRM
An experiment to determine whether the putative VSRM could mediate cell shortening in the presence of L-type Ca 2ϩ channel blockers is shown in Fig. 4 . Voltage protocols were based on those shown in Fig. 2 A, but the conditioning train under conditions selective for the putative VSRM was extended to 30 steps. When CdCl 2 (120-200 M) was used, it was applied transiently during the 4-s holding period and removed after completion of the test depolarizing step. The use dependence of nifedipine (30-60 M) mandated it to be present continuously throughout the experiment. In later experiments, NiCl 2 (12 mM) was used. Experiments under CICRselective control conditions were completed before application of L-type Ca 2ϩ channel blockers. In some cells, small phasic inward currents were activated by depolarization despite the presence of L-type Ca 2ϩ channel blockers. Data from these cells were not included in the calculation of the cell shortening curve seen in Fig. 4 C. With depolarizations to test potentials negative to 0 mV, membrane current in the remainder of cells was inward and maintained (Fig. 4 B) . With test depolarizations to potentials of Ϫ20 mV and more pos- 
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The VSRM in Rabbit Is Explained by CICR itive, inactivating early outward current typical of I to was activated. Application of the L-type Ca 2ϩ channel blockers nifedipine or CdCl 2 did not abolish cell shortening but maximum amplitude was reduced to 60% of that under CICR-selective conditions in paired controls (Fig. 4 C) . The voltage threshold for cell shortening remained at Ϫ50 mV and cell shortening reached a peak at Ϫ20 mV. With depolarization to more positive potentials cell shortening did not reach a plateau but decreased, reaching a nadir at 40 mV. The shape of the cell shortening versus voltage curve was therefore analogous to that shown in Fig. 2 C when I Ca(L) was present and reflected to some extent the voltage dependence of I Ca(L) . With depolarization to yet further positive potentials, the shape of the curve deviated from that recorded with I Ca(L) present and described a second rise.
The effect on maximum cell shortening amplitude of different L-type Ca 2ϩ channel blockers in varying concentration is shown in Fig. 5 . With small numbers of cells in each group, increasing potency of L-type Ca 2ϩ channel blockade seemed to produce increasing suppression of cell shortening amplitude.
Tail contractions occurred on repolarization to Ϫ80 mV from test potentials positive to 40 mV in a proportion of cells (18/29) under CICR-selective conditions (Fig. 4 B) . This phenomenon occurred also in a proportion of cells (9/26) under conditions selective for the putative VSRM (Fig. 6 A) . This suggested that L-type Ca 2ϩ channels were open during test depolarizations under conditions selective for the putative VSRM. The effect of different L-type Ca 2ϩ channel blockers in varying concentration on repolarization-activated tail contractions is shown in Fig. 6 B. Once again, in groups with small numbers of cells, repolarization-activated tail contractions appeared less frequently as potency of L-type Ca 2ϩ channel blockade increased.
In a separate series of experiments, the effect was established of NiCl 2 (12 mM) on cell shortening under conditions selective for the putative VSRM (Fig. 7 A) . Voltage protocols were based on those shown in Fig. 4 A but the conditioning train consisted of action potentials at 0.5 Hz for 30 s under current clamp before depolarization to the holding potential of Ϫ60 mV under voltage clamp. Lignocaine (400 M) and NiCl 2 (12 mM) were applied transiently during the 4-s holding period and removed after completion of the test depolarizing step. Under CICR-selective conditions in paired controls, the conditioning period under current clamp was reduced to 10 s, the holding potential was Ϫ40 mV, and lignocaine and NiCl 2 were not applied. The effect of NiCl 2 was unequivocal. Maintained inward current during small depolarizations was blocked. There were no occurrences of phasic inward current. Cell shortening and repolarization tail contractions were blocked completely at all potentials (Fig. 7, B and C) .
The Persistence of L-type Ca 2ϩ Current under Conditions Presumed to be Selective for the Putative VSRM
Together, the results described above suggested strongly the presence of unblocked I Ca(L) under conditions se- lective for the putative VSRM in the presence of nifedipine (30-60 M) or CdCl 2 (120-200 M). This may have been undetectable in the presence of overlying I to . An experiment was designed to test directly this hypothesis (Fig. 8 A) . Cells were held under voltage clamp at a holding potential of Ϫ60 mV and depolarizing steps were applied to potentials between Ϫ50 mV and 80 mV at a repeat frequency of 2 Hz. Na ϩ channels were blocked by application of lignocaine (500 M) 3 s before the first step and L-type Ca 2ϩ channel blockers were applied. Either CdCl 2 (120 M) or NiCl 2 (12 mM) were applied 3 s before the start of the voltage protocol and simultaneously with lignocaine. When nifedipine (30 M) was used, it was added during voltage clamp steps from Ϫ45 to 0 mV at 0.5 Hz while its use-dependent effect was becoming established and the voltage protocol was started 30 s later. Conditioning voltage clamp steps were otherwise not used. The I to blocker, 4AP (5 mM), and the I Cl(Ca) blocker SITS (2 mM) were then added and the cell was superfused for 5 min before the protocol was repeated. Inward current records during depolarization to Ϫ10 mV are shown before (control) and after block of I to and I Cl(Ca) (Fig. 8 B) . A component of unblocked inward current was detectable and was maximal at Ϫ10 mV but was blocked completely by NiCl 2 (12 mM) (Fig. 8 C) .
The Contribution of Na ϩ /Ca 2ϩ Exchange to the Putative VSRM
Typically, cell shortening under conditions selective for the putative VSRM was tonic and maintained at test potentials between Ϫ50 and Ϫ40 mV (Fig. 4 B) . At test potentials between Ϫ40 and 20 mV, the amplitude of cell shortening was dependent on the potency of L-type Ca 2ϩ channel blockade (ibid.). It was noted also that the potency of L-type Ca 2ϩ channel blockade affected the form of cell shortening. Cell shortening under conditions selective for the putative VSRM could be phasic in the presence of nifedipine (30-60 M) or CdCl 2 (120 M) (e.g., Figs. 4 B, 6 A, 9 A, and 14 A). Cell shortening in the presence of CdCl 2 (Ն150 M) or NiCl 2 (12 mM) was never phasic (e.g., Figs. 7 B and 11 A).
With depolarizations to strongly positive potentials, cell shortening was tonic and progressive throughout the duration of the test step. The form of cell shortening under conditions selective for CICR and the putative VSRM was examined quantitatively (Fig. 9 A) . The times to onset and peak of cell shortening are shown as functions of test potential in Fig. 9 , B and C, respectively. Under CICR-selective conditions, these time intervals shortened as test depolarizations were made to potentials approaching 0 mV where they were at a minimum. This corresponded with the well known effect of shortening of the time to peak of I Ca(L) over this voltage range. As depolarizations were made to more posi- tive potentials, the time intervals became progressively longer and time to peak shortening tended asymptotically toward the depolarizing step duration of 310 ms. This reflected the tonic progressive nature of cell shortening at positive potentials whereby cells continued to shorten throughout the period of depolarization. The curves defining the form of cell shortening under conditions selective for the putative VSRM were comparable in shape to those under CICR-selective conditions. These features of late-peaking progressive cell shortening or an increase in intracellular [Ca 2ϩ ] occurring with a significant delay after depolarization are typical of those described for EC coupling mediated by Na ϩ / Ca 2ϩ exchange Beuckelmann and Wier, 1989; Nuss and Houser, 1992; Sham et al., 1992; Bouchard et al., 1993) . This mode of EC coupling is expected to operate during depolarizations to strongly positive potentials under our CICR-selective conditions. The similarity between the shapes of the curves obtained under the two sets of conditions illustrated in Fig. 9 , B and C, raised the possibility that EC coupling mediated by Na ϩ /Ca 2ϩ exchange might also have operated under conditions selective for the putative VSRM. In turn, EC coupling mediated by Na ϩ /Ca 2ϩ exchange may have contributed to the upturn at positive potentials of the cell shortening versus voltage curve. A number of experiments were performed to test this hypothesis. The driving force for Na ϩ /Ca 2ϩ exchange is given by E m -E NCX (the equilibrium potential for Na ϩ /Ca 2ϩ exchange) so an experiment was devised to produce an abrupt increase in E NCX by increasing rapidly extracellular [Na ϩ ] (Fig. 10 A) . This produced selective inhibition of outward Na ϩ /Ca 2ϩ exchange current. For this series of experiments, cells were stored in a low sodium/calcium solution until use and this solution was also used as the control superfusing solution. Cells underwent 10 conditioning steps of 300 ms duration under voltage clamp before each test step. The conditioning steps were applied to 0 mV rather than 60 mV in order to produce calcium influx via L-type Ca 2ϩ channels. A holding potential of Ϫ65 mV was set for conditions selective for the putative VSRM and Ϫ45 mV for CICR. Na ϩ and L-type Ca 2ϩ current were blocked under conditions selective for the putative VSRM by rapid application of lignocaine (500 M) and CdCl 2 (150 M) at the onset of the 4-s holding period. Cell shortening was elicited by voltage steps between Ϫ40 and 80 mV in 40-mV increments. The rapid increase in extracellular [Na ϩ ] was achieved by switching the superfusate to a Tyrode solution containing 146 mM Na ϩ 2 s before test depolarizations. The experiments were performed in paired fashion with CICR experiments completed before application of lignocaine and CdCl 2 under conditions selective for the putative VSRM. Assuming no change in intracellular [Na ϩ ] or [Ca 2ϩ ] during the time course of the switch, we calculated that E NCX would change by 86 mV. However, subsarcolemmal Na ϩ 
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The VSRM in Rabbit Is Explained by CICR accumulation during exposure to the higher [Na ϩ ]-containing solution must have attenuated the ⌬E NCX achieved in practice. After the solution switch, holding current under voltage clamp deviated over the following 2 s, by Ϫ0.29 Ϯ 0.04 pA pF Ϫ1 at Ϫ45 mV under CICR-selective conditions and by Ϫ0.24 Ϯ 0.04 pA pF Ϫ1 at Ϫ65 mV under conditions selective for the putative VSRM (n ϭ 13). This deviation was not significantly different between the two sets of conditions (P ϭ 0.55). Peak I Ca(L) amplitude was Ϫ3.2 Ϯ 0.18 pA pF Ϫ1 at 0 mV in low sodium/ calcium solution and Ϫ3.1 Ϯ 0.21 pA pF Ϫ1 after the switch to Tyrode solution containing 146 mM Na ϩ (n ϭ 13, P ϭ 0.57, Fig. 10 B) . Within this population of cells, the form of cell shortening under conditions selective for the putative VSRM in the presence of CdCl 2 (150 M) was never phasic. Application of 146 mM Na ϩ had a prominent inhibitory effect on cell shortening under conditions selective either for CICR or the putative VSRM (Fig. 10 C) . The tonic cell shortening seen under conditions selective for the putative VSRM was inhibited substantially (Fig. 10 D) . Phasic cell shortening under CICR-selective conditions was also inhibited.
KB-R7943 is an Na ϩ /Ca 2ϩ exchange-blocking drug with preferential effects on outward over inward Na ϩ / Ca 2ϩ exchange current (Watano et al., 1996) . Its effects on cell shortening were examined. Voltage protocols were based on those shown in Fig. 10 A, but the basic superfusate was normal Tyrode, lignocaine (500 M) was present during the holding period under CICR- Figure 12. (A, i) The effect of NiCl 2 (12 mM) on inward Na ϩ /Ca 2ϩ exchange current activated under voltage clamp at Ϫ70 mV by rapid application of caffeine (10 mM) (C m ϭ 164 pF). (ii) The effect of NiCl 2 (12 mM) on outward Na ϩ /Ca 2ϩ exchange current activated under voltage clamp at 0 mV by a rapid switch to outward Na ϩ /Ca 2ϩ exchange activating solution (RMP ϭ resting membrane potential). Cell shortening is shown in the bottom panel. (B, i). Peak inward Na ϩ /Ca 2ϩ exchange current density following application of 12 mM NiCl 2 (n ϭ 7). (ii) Peak outward Na ϩ /Ca 2ϩ exchange current after application of 12 mM NiCl 2 (n ϭ 7, asterisk indicates significant difference at the 95% level by Student's paired t test).
selective conditions, and all solutions contained 0.02% DMSO (Fig. 11 A) . The onset of action of KB-R7943 took up to 3 min and was only partly reversible. For these reasons, control measurements were made under conditions selective for first CICR and then the putative VSRM before adding KB-R7943 (2 M) and remeasuring.
KB-R7943 (2 M) produced a Ϫ0.30 Ϯ 0.11 pA pF Ϫ1 change in holding current under voltage clamp at Ϫ45 mV and a Ϫ0.36 Ϯ 0.13 pA pF Ϫ1 change at Ϫ65 mV (n ϭ 10, P ϭ 0.36) compatible with its I K1 blocking effect. L-type Ca 2ϩ current at 0 mV under CICR-selective conditions was reduced from Ϫ6.4 Ϯ 0.7 pA pF Ϫ1 to Ϫ3.5 Ϯ 0.6 pA pF Ϫ1 in KB-R7943 (53 Ϯ 7% of control, n ϭ 10, P Ͻ 0.001). In this population of cells in which conditions selective for the putative VSRM were established in the presence of CdCl 2 (150 M), the form of cell shortening was never phasic. Under these conditions, cell shortening was reduced by KB-R7943 (2 M) at all potentials, and to 29 Ϯ 7% of control at 80 mV (P Ͻ 0.001; Fig. 11, B and C) . KB-R7943 inhibited phasic as well as tonic cell shortening under CICR-selective conditions compatible with the demonstrated inhibitory effect on I Ca(L) .
NiCl 2 (12 mM) produced complete block of cell shortening at all potentials (Fig. 7) . NiCl 2 is known to be a potent blocker of Na ϩ /Ca 2ϩ exchange as well as L-type Ca 2ϩ current and its effects may have been mediated partly by this effect. An experiment was performed to establish the completeness of block of Na ϩ /Ca 2ϩ exchange by NiCl 2 . Inward Na ϩ /Ca 2ϩ exchange was activated by rapid application of caffeine to myocytes held 
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The VSRM in Rabbit Is Explained by CICR under voltage clamp at Ϫ70 mV ( Fig. 12 A(i) ). This produced inward Na ϩ /Ca 2ϩ exchange current and cell shortening. NiCl 2 (12 mM) was then applied 4 s before reapplication of caffeine. The conditioning protocol was identical to that used in experiments investigating the effect of NiCl 2 on the putative VSRM (Fig. 7 A) and consisted of action potentials under current clamp at 0.5 Hz for 30 s. NiCl 2 produced an outward change in the holding current, often with the development of cell shortening, compatible with block of background inward Na ϩ /Ca 2ϩ exchange current. Cell shortening on reapplication of caffeine was exaggerated by NiCl 2 . This was compatible with inhibition of extrusion by Na ϩ /Ca 2ϩ exchange of released Ca 2ϩ . Peak inward current was measured with respect to steady-state current in the presence of caffeine and was reduced by NiCl 2 to 3 Ϯ 3% of control (P Ͻ 0.01; Fig. 12 B(i) ). In 6/7 cells, block was complete. In an analogous experiment, outward Na ϩ /Ca 2ϩ exchange was activated by rapid application of outward Na ϩ /Ca 2ϩ exchange-activating solution to cells held under voltage clamp at 0 mV ( Fig. 12  A(ii) ). Cell shortening under these conditions was attenuated by NiCl 2 . This was compatible with inhibition of Na ϩ /Ca 2ϩ exchange-mediated inward flux of Ca 2ϩ . Peak outward current was reduced by NiCl 2 (12 mM) to 20 Ϯ 6% of control although part of the residual current may have represented I Cl(Ca) (P Ͻ 0.01; Fig. 12  B(ii) ). Open bars indicate conditioning steps of 300 ms duration and black bars indicate conditioning steps of 600 ms duration (asterisk indicates significant difference at the 95% level by Student's paired t test).
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Griffiths and MacLeod
The Effect of Isoprenaline and Increased SR Ca 2ϩ Content on the Putative VSRM
Published work on the putative VSRM has demonstrated that dialysis with a high concentration of cAMP is necessary for its demonstration when patch pipettes are used (Hobai et al., 1997b; Ferrier et al., 1998) . A prominent affect of elevated cAMP is to increase SR Ca 2ϩ content and this is known to be a major determinant of the gain of CICR. This activation within the ␤-adrenergic pathway is known also to increase I Ca(L) amplitude and increase resistance to L-type Ca 2ϩ channel blockers (McDonald et al., 1994; Hobai et al., 2000) . All of these effects are important under conditions where I Ca(L) is blocked incompletely. Preliminary experiments in our lab using the twostep voltage protocol proposed by Ferrier and Howlett (1995) demonstrated that putative VSRM contractions at Ϫ40 mV were present only in cells exhibiting signs of SR Ca 2ϩ overload. The hypothesis was developed, therefore, that under the influence of elevated intracellular cAMP, CICR could mediate EC coupling with features resembling the putative VSRM. To test this hypothesis, intracellular levels of cAMP were increased by inclusion of isoprenaline in the superfusate (Callewaert et al., 1988; Hussain and Orchard, 1997) . Voltage protocols were based on those shown in Fig. 11 A, but solutions did not contain DMSO. 20 conditioning steps to 60 mV were applied and the membrane was repolarized from the final conditioning step to the holding potential (Fig. 13 A) . L-type Ca 2ϩ channels were blocked by CdCl 2 (120 M). Experiments under control conditions were always performed before application of isoprenaline (1 M) at the onset of the conditioning period.
SR Ca 2ϩ content was assessed by integration of the inward current activated by rapid application of caffeine (10 mM). This represented transsarcolemmal extrusion by Na ϩ /Ca 2ϩ exchange of Ca 2ϩ released from the SR. Released Ca 2ϩ distributes chiefly within the cytoplasmic intracellular compartment and a scaling factor of 0.65 was applied to account for the proportion of intracellular volume occupied by mitochondria. SR Ca 2ϩ content was therefore expressed in units of mol l Ϫ1 of accessible cell volume (a.c.v.). Isoprenaline (1 M) produced an increase in SR Ca 2ϩ content from 25.9 Ϯ 4.3 mol l Ϫ1 a.c.v. to 59.0 Ϯ 8.6 mol l Ϫ1 a.c.v. (n ϭ 7, P Ͻ 0.001). Spontaneous cell shortening did not occur. Under CICR-selective conditions, I Ca(L) increased from Ϫ5.5 Ϯ 0.7 pA pF Ϫ1 to Ϫ8.3 Ϯ 1.1 pA pF Ϫ1 (n ϭ 11, P Ͻ 0.05). Isoprenaline (1 M) had little effect on the amplitude of cell shortening under these conditions. A reduction in cell shortening during the voltage step to 40 mV was observed with no significant change at other potentials (Fig. 13, A and B) . Under conditions selective for the putative VSRM, marked effects of isoprenaline were observed on the form of cell shortening in individual cells. In two cells, shortening at test depolarizations to Ն40 mV became rapid and phasic ( Fig. 13 A, right column) . At these potentials, cell shortening was always of late onset, progressive and with a late peak in the absence of isoprenaline. In addition, maximum cell shortening amplitude at test depolarizations of Ϫ40 and 0 mV was increased in the presence of isoprenaline.
The effect on cell shortening of adjustment of the conditioning step duration from 300 to 600 ms was assessed (Fig. 14) . This experiment was devised as a more selective test of the effect of increased SR Ca 2ϩ content on cell shortening. Voltage protocols were based on those shown in Fig. 13 A, but Na ϩ channels were blocked by TTX (30-40 M) or lignocaine (500 M). Experiments under CICR-selective conditions were completed before conditions selective for the putative VSRM were established in the presence of CdCl 2 (120 M).
Under these conditions SR Ca 2ϩ content was increased from 35.8 Ϯ 5.6 mol l Ϫ1 a.c.v. to 49.4 Ϯ 5.0 mol l Ϫ1 a.c.v. (n ϭ 11, P Ͻ 0.01). Spontaneous cell shortening was not induced and I Ca(L) amplitude was reduced by 600 ms conditioning steps from Ϫ5.3 Ϯ 0.6 pA pF Ϫ1 to Ϫ4.6 Ϯ 0.5 pA pF Ϫ1 (n ϭ 19, P Ͻ 0.05). Under CICR-selective conditions, cell shortening at 0 mV was increased, but remained unchanged at other test depolarizations (Fig. 14 B) . Under conditions selective for the putative VSRM marked effects were seen in individual cells. In one cell, shortening at test depolarizations of Ն40 mV became rapid and phasic (Fig. 14 A, right column). At these potentials, cell shortening was always of late onset, progressive, and with a late peak during conditioning with 300-ms steps. Maximum cell shortening amplitude during conditioning with 600-ms steps was increased at Ϫ40, 0, and 40 mV, but remained unchanged at 80 mV (Fig. 14 B) .
D I S C U S S I O N
We have demonstrated that when holding potential was adjusted in order to allow the hypothesized VSRM to operate alongside CICR, there was a change in the voltage threshold for cell shortening to a more negative value. This was in qualitative agreement with the result of Howlett et al. (1998) , but we recorded a change of Ϫ10 mV in contrast to the Ϫ20 mV recorded in that study. This was accompanied by a change of the same magnitude in the voltage threshold for I Ca(L) . Indeed, this phenomenon is also evident in the work of Howlett et al. (1998) (see their Fig. 2 D) . Inspection of membrane current records, however, suggested that cell shortening at threshold potentials was occurring in the absence of inward current. As this was the case when holding potential was set in a range for selective demonstration of CICR as well as after adjustment to more negative values, we reasoned that I Ca(L) might be present but undetected. The nifedipine-sensitive current obtained by subtraction demonstrated that cell 370 The VSRM in Rabbit Is Explained by CICR shortening at these negative test potentials was always accompanied by I Ca(L) and confirmed that I Ca(L) could be detected at a test potential of Ϫ50 mV when depolarizations were applied from a holding potential of Ϫ60 mV. This finding suggested strongly that under these conditions, cell shortening was dependent on CICR triggered by I Ca(L) and not on a combination of CICR and putative VSRM. These findings in relation to the putative VSRM are in accordance with the earlier study of "small depolarizations" by Talo et al. (1990) . Under the terms of the local control theory for CICR (Stern, 1992) , gain is variable and greatest during test depolarizations to negative potentials. It is at these potentials that the electrochemical gradient for Ca 2ϩ and therefore unitary L-type channel Ca 2ϩ flux is greatest (Wier et al., 1994) . At these potentials therefore, the low amplitude I Ca(L) recorded by nifedipine subtraction is expected to be significant with respect to its ability to trigger CICR and cell shortening. This argument emphasizes the importance of complete exclusion of I Ca(L) before ascribing cell shortening to the hypothesized VSRM. The approach taken by Ferrier and Howlett (1995) and also in their later work relied heavily on the demonstration of cell shortening at Ϫ40 mV. They reasoned, but did not demonstrate convincingly, that I Ca(L) was not activated at this potential. It is now clear that this is not the case.
The persistence of repolarization-activated tail contractions (London and Krueger, 1986; Beuckelmann and Wier, 1988) in a proportion of cells exposed to L-type Ca 2ϩ channel blockers suggested strongly that I Ca(L) was blocked incompletely. This occurred despite the use of nifedipine in concentrations an order of magnitude greater and CdCl 2 in concentrations up to twice those in earlier studies. It was clear from our preliminary experiments that the I to became prominent when the holding potential was Ϫ60 mV. This current is known to have a comparable time course but an opposite direction to I Ca(L) and was likely to have played a part in masking underlying I Ca(L) . In the presence of verapamil (2 M), persisting inward current may be observed even in the raw membrane currents in the "control experiment" of Howlett et al. (1998) (their Fig. 1 B) . We too observed this occasionally during the experiments illustrated in Fig. 4 . We proceeded therefore, by blocking I to , to establish to what extent I Ca(L) was present under experimental conditions designed to demonstrate the putative VSRM. It was shown that even at high concentration, nifedipine and CdCl 2 were unable to block completely I Ca(L) . Dependency of cell shortening on CICR was confirmed by the correlation between cell shortening and the concentration of L-type Ca 2ϩ channel blocker present (Fig. 5) . To emphasize this point, both I Ca(L) and cell shortening were blocked completely by NiCl 2 . It is further emphasized that L-type Ca 2ϩ channel blockers are less effective as holding potential becomes more negative (Kokubun et al., 1986; Lansman et al., 1986 ) with phosphorylation of the channel (Hobai et al., 2000) or as experimental temperature increases (Allen and Chapman, 1992) . NiCl 2 in the lower concentration of 200 M had a significant inhibitory effect on cell shortening in guinea-pig (Ferrier and Howlett, 1995) . At this concentration, T-type Ca 2ϩ current is blocked selectively over L-type Ca 2ϩ current and this current is expressed in guinea-pig but not rabbit myocytes (Vassort and Alvarez, 1994; Bers, 2001 ). This result suggested strongly a role for T-type Ca 2ϩ current triggered CICR (Sipido et al., 1998) .
When holding potential was adjusted in order to allow the hypothesized VSRM to operate alongside CICR, the overall shape of the cell shortening versus voltage curve remained bell shaped without a plateau at positive potentials. In this respect we failed to reproduce the findings of Ferrier and Howlett (1995) . A broad maximum of cell shortening or the Ca 2ϩ transient as a function of voltage has often been observed in previous work on CICR however. Thus, large amplitude responses were recorded at negative and positive potentials despite low amplitude I Ca(L) Callewaert et al., 1988) . This can be ascribed to high gain at negative potentials (Wier et al., 1994) and can be explained by the many nonlinearities in the system at positive potentials (Callewaert, 1992) . In many of their experiments, Ferrier and Howlett (1995) did not extend their observations to very positive potentials and may have interpreted a broad peak in their curves mistakenly as a plateau. In one experiment, a sigmoid curve was obtained with observations to potentials of 80 mV (Ferrier and Howlett, 1995) . In that experiment the holding potential was Ϫ55 mV and Na ϩ channel blockers were not used. It is relevant, therefore, that I Na has been shown to contribute to a sigmoid cell shortening versus voltage curve under just these conditions (Piacentino et al., 2000) . In the current report, lignocaine in a concentration of at least 400 M or TTX in a concentration of 30 M were used and there was never any reason to suspect that I Na was present. Furthermore, in the experiment of Ferrier and Howlett (1995) demonstrating a sigmoid curve to potentials of 80 mV, L-type Ca 2ϩ channel blockers were not present and CICR therefore operated alongside the putative VSRM. A further factor in the experiment of Ferrier and Howlett (1995) was the use of reduced [Na ϩ ] in the superfusate and this may have contributed to increased SR Ca 2ϩ content. SR Ca 2ϩ content is an important determinant of CICR gain and instances have already been quoted of increased SR Ca 2ϩ content or increased experimental temperature generating a sigmoid cell shortening vs. voltage curve (Vornanen et al., 1994; Wasserstrom and Vites, 1996) . In our experiments, increased SR Ca 2ϩ content did not generate a sigmoid curve but responses in individual cells were fundamentally changed in that high ampli-tude phasic cell shortening occurred at positive potentials. That isoprenaline did not increase maximum cell shortening may be explained by phosphorylation of troponin I and reduced myofilament sensitivity to Ca 2ϩ (Okazaki et al., 1990; Bers, 2001) .
Our approach to assessment of the contribution of Na ϩ /Ca 2ϩ exchange to the hypothesized VSRM differed from that of Ferrier et al. (2000) . They measured the amplitude and voltage dependence of the sustained Ca 2ϩ transient in cells under steady-state superfusion with 50 or 100 mM Na ϩ and found it to be independent of [Na ϩ ]. The sustained Ca 2ϩ transient persisted under these conditions. It was concluded that the sustained component was not dependent on Na ϩ /Ca 2ϩ exchange. Consideration of the mode of operation of Na ϩ /Ca 2ϩ exchange calls this conclusion into doubt. In the steadystate, intracellular [Na ϩ ] would rise with or without a significant drop in subsarcolemmal [Ca 2ϩ ] in response to increased superfusate [Na ϩ ]. One or both of these effects would attenuate any possible effect on E NCX . For this reason, we investigated the effects of an abrupt increment in superfusate [Na ϩ ] that produced an 86 mV change in E NCX during the time course of the test depolarization. Under the conditions of this experiment, a significant reduction in tonic cell shortening was observed. Superfusate [Ca 2ϩ ] remained unchanged during the solution switches and no effects on CICR were expected. Phasic shortening under CICR-selective conditions, however, was reduced and this finding is difficult to explain. It could be argued that the reduced [Na ϩ ] superfusate used in these experiments might have contributed to SR Ca 2ϩ overload, but no signs of this were observed. Even if SR Ca 2ϩ overload had been present, individual cell shortening records and the cell shortening versus voltage curves were of conventional form. In a separate experiment, they found that sustained cell shortening persisted when NiCl 2 (2 mM) was applied rapidly some seconds after its initiation . It is likely, however, that the maintaining factors for the sustained component of cell shortening are different from those governing its initiation. As NiCl 2 was applied during a steady-state period, then net sarcolemmal flux was by definition zero. It is conceivable that the capacity of the SR to take up Ca 2ϩ was exhausted by inward Ca 2ϩ flux during a prolonged period at a positive membrane potential. Application of NiCl 2 and block of the Na ϩ /Ca 2ϩ exchange at this time might have unpredictable effects. The traces seen in Fig.  12 A show that NiCl 2 caused membrane current to become more outward and provoked low amplitude cellshortening oscillation. This implies that under these conditions, NiCl 2 caused intracellular [Ca 2ϩ ] to rise and, therefore, by inference, blocked background inward Na ϩ /Ca 2ϩ exchange current. In our experiments with NiCl 2 it was applied 4 s before test depolarizations thus allowing its effects to develop. Used in this way, cell shortening was abolished.
When I Ca(L) was blocked partially by nifedipine or CdCl 2 , cell shortening was suppressed partially and the curve retained its basic bell shape, but a secondary rise was present at positive potentials. This curve resembled superficially the sigmoid relationship claimed for the hypothesized VSRM. Under the influence of a hypothesized mechanism for EC coupling dependent only on membrane voltage, time to the onset and peak of cell shortening would be expected to shorten with more positive test depolarizations as the voltage sensor moved more rapidly through a stronger electric field. However, this feature was not observed and the form of cell shortening at these potentials under conditions selective for the putative VSRM resembled that under CICR-selective conditions.
A possible explanation for the appearance of a secondary rise in the shape of the curve relates to the interrelationship between L-type Ca 2ϩ channel flux and operation of Na ϩ /Ca 2ϩ exchange. Depolarization-activated I Ca(L) causes Ca 2ϩ to accumulate within the subsarcolemmal space and therefore at the cytoplasmic face of the Na ϩ /Ca 2ϩ exchange protein. This accumulation results in a positive change of E NCX , thus reducing the electrochemical gradient for inward Ca 2ϩ flux by Na ϩ /Ca 2ϩ exchange. When I Ca(L) is blocked, this inhibitory effect on Na ϩ /Ca 2ϩ exchange is reduced, thus allowing unhindered Na ϩ /Ca 2ϩ exchange-mediated Ca 2ϩ entry at positive potentials. It was seen that while CdCl 2 (120 M) produced less complete block of I Ca(L) than nifedipine (30 M), the block of cell shortening was greater with CdCl 2 . This apparent anomaly may be explained by the inhibitory effect of CdCl 2 on Na ϩ / Ca 2ϩ exchange (Hobai et al., 1997a) .
In conclusion, a fraction of I Ca(L) remains unblocked in the presence of L-type Ca 2ϩ channel blockers under conditions necessary for demonstration of the hypothesized VSRM. The currents are masked by I to , which becomes less inactivated at negative holding potentials. When the sensitive method of current subtraction is employed, it is clear that cell shortening never occurs in the absence of I Ca(L) . When complete block of I Ca(L) is achieved, cell shortening is abolished. Our results are also compatible with a contribution from Na ϩ /Ca 2ϩ exchange to the hypothesized VSRM with particular reference to the tonic component of shortening at positive potentials. We are in agreement with the conclusions of Piacentino et al. (2000) . Our results show no significant VSRM and thus any possible contribution of a VSRM to cardiac EC coupling appears to be negligible. A quantitative analysis of the contribution of I Ca(L) to cell shortening under these experimental conditions will follow. It has been asserted that it is not possible to draw conclusions about the putative VSRM when its properties have not been reproduced exactly (Ferrier and Howlett, 2001) . We reinforce the argument that cell shortening or a calcium transient cannot be as-
